Advertisement
Advertisement
Lorviqua

Lorviqua

Basic Prescribing Info
Contents
Lorlatinib
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED05 - lorlatinib ; Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement